景峯醫藥(000908.SZ):控股股東變更為洲裕能源、實控人變更為徐歡霞
格隆匯3月4日丨景峯醫藥(000908.SZ)公佈,公司於2022年3月4日收到葉湘武的通知,獲悉葉湘武及其一致行動人協議轉讓給北京洲裕能源科技有限責任公司(下稱“洲裕能源”)的43,988,718股股票已於2022年3月3日完成過户登記手續。
根據相關協議安排,本次交易完成後,葉湘武及其一致行動人共計持有122,975,210股,佔公司總股本的13.98%;同時,本次交易過户之日起葉湘武本人直接持有的剩餘股份(120,847,486股,佔公司總股本的13.74%)所對應之表決權自本次協議轉讓完成過户之日起三年內不可撤銷地委託給洲裕能源。洲裕能源直接持有公司43,988,718股股份,並通過表決權委託的方式擁有公司120,847,486股股份所對應的表決權。洲裕能源在景峯醫藥擁有表決權的股份數量合計為164,836,204股,佔公司總股本的18.74%,成為可支配公司最大單一表決權的股東,洲裕能源成為公司控股股東,公司實際控制人由葉湘武變更為徐歡霞。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.